Clinical trial
Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in…
NCT00213018 · Population Council, Other · Completed
Key facts
| NCT number | NCT00213018 |
|---|---|
| Title | Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission |
| Official title | A Trial to Assess Expanded Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing STI/HIV Transmission |
| Lead sponsor | Population Council, Other |
| Collaborators | Bill and Melinda Gates Foundation FHI 360 National Institute of Allergy and Infectious Diseases (NIAID) NIH Medical Research Council, South Africa University of Cape Town University of Limpopo United… |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Chlamydia Trachomatis, Neisseria Gonorrhoeae, Trichomonas Vaginitis, Syphilis |
| Intervention type | Drug |
| Interventions | Carraguard (PC-515) |
| Enrollment | 400 |
| Start date | Oct 1, 1999 |
| Completion | Jan 1, 2002 |
| First posted | Sep 21, 2005 |
| Last update posted | Aug 14, 2017 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: